compounded tirzepatide frederick – tru2u Compounded Tirzepatide - The IV
Description
Head-to-Head vs Semaglutide (Frias et al., 2021): Tirzepatide demonstrated superior glycemic control compared to semaglutide, supporting the dual-agonist advantage
Obese patients with higher BMIs are at higher risk for having vitamin B12 deficiency and weight loss may potentially worsen the B12 deficiency
The advantage is eliminated reconstitution error
Costs for compounded tirzepatide typically range from $200 to $500 per month, depending on dose and pharmacy
M.et al (2019)
